Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01896 |
| Species: | Homo sapiens |
| Position : | chr9:21074270-21076270 |
| Year: | 2018 |
| Title: | The Nuclear Matrix Protein SAFA Surveils Viral RNA and Facilitates Immunity by Activating Antiviral Enhancers and Super-enhancers |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 31513772 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | LuNE |
| CVCL ID: | |
| Cell Type: | prostate carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Antiviral immune enhancer activation study, Chromatin interaction assay |
| High Throughput Method: | |
| Low Throughput Method: | 3C, Immunofluorescence, RT-RT-qPCR, Western blot |
| Target gene : | IFNB1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|